Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
With
This study is designed to investigate and examine the time to progression and overall survival for CMB305 in combination with atezolizumab or atezolizumab alone in the treatment of participants with sarcoma expressing NY-ESO-1 protein.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
